Side-effects of antithrombotic therapy.
Levine
M N
MN
Anderson
D R
DR
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D003374:Coumarins / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000139:chemically induced* / Q000503:physiopathology; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D014812:Vitamin K; D006493:Heparin; C030123:coumarin